EU ingredient rules · 1 min read

Alpha-Damascone in cosmetics: EU rules

Quick answer: Alpha-Damascone is a restricted cosmetic ingredient in the EU: Annex III (entry 157) allows it only within set limits. CosIng lists its functions as fragrance and perfuming.

Key facts

Alpha-Damascone at a glance
INCI nameALPHA-DAMASCONE
CAS number23726-94-5 / 43052-87-5
EC number245-845-8
EU statusRestricted (Annex III, entry 157)
Functions (CosIng)Fragrance, Perfuming

What it does in a product

  • Fragrance: Adds or covers a scent.
  • Perfuming: Used to add scent, and listed in CosIng under a perfuming name.

Annex III: restricted substances, entry 157

Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.

The entry is listed as 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one; 1-(2,6,6-Trimethylcyclohexa-1,3-dien-1-yl)-2-buten-1-one; 1-(2,6,6-Trimethyl-3-cyclohexen-1-yl)-2-buten-1-one; (Z)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one; (E)-1-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-2-buten-1-one

Maximum concentration in the ready-to-use product:

Product type or body part:

Other conditions:

16 - The sum of those substances used in combination should not exceed the limits given as “Maximum concentration in ready for use preparation”.

Most recent legal act listed by CosIng for this entry: Regulation (EU) 2023/1545.

Why it matters for shelf life

The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.

Not sure how to read a label? What an INCI name is · How ingredient lists work

Source

European Commission, CosIng (Cosmetic Ingredients database), entries for ALPHA-DAMASCONE and Annex III/157, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.